Whole Body Skeletal Muscle Transduction in Neonatal Dogs with AAV-9
Gene therapy of muscular dystrophy requires systemic gene delivery to all muscles in the body. Adeno-associated viral (AAV) vectors have been shown to lead to body-wide muscle transduction after a single intravascular injection. Proof-of-principle has been demonstrated in mouse models of Duchenne muscular dystrophy and limb girdle muscular dystrophy. Before initiating clinical trials, it is important to validate these promising results in large animal models. More than a dozen canine muscular dystrophy models have been developed. Here, we outline a protocol for performing systemic AAV gene transfer in neonatal dogs. Implementing this technique in dystrophic dogs will accelerate translational muscular dystrophy research.
- Analysis of Gene Order Evolution Beyond Single-Copy Genes
- Detection of rpoB Gene Mutations Using Helicase-Dependent Amplification
- Herpes Simplex Virus-Cell Interactions Studied by Immunogold Cryosection Electron Microscopy
- Cellular MicroRNA Sensors Based on Luciferase Reporters
- Rapid Purification of DNA Topoisomerase II Containing a Hexahistidine Tag by Metal Ion Affinity Chromatography
- DNA-Based Vaccination Primes Tumor-Rejecting T-Cell Responses
- The Use of the MegaBACE for Sequencing and Genotype Analysis
- Identify Intronic MicroRNA with Bioinformatics
- Rapid Sequence Scanning Mutagenesis Using In Silico Oligo Design and the Megaprimer PCR of Whole Plasmid Method (MegaWHOP)
- Stable Gene Delivery to CNS Cells Using Lentiviral Vectors